Minerva Neurosciences
NERV
85 hedge funds and large institutions have $163M invested in Minerva Neurosciences in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 8 closing their positions.
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
8% more funds holding
Funds holding: 79 → 85 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.34% less ownership
Funds ownership: 9.63% → 9.29% (-0.34%)
8% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 26
31% less capital invested
Capital invested by funds: $236M → $163M (-$73M)
64% less call options, than puts
Call options by funds: $66K | Put options by funds: $181K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.25M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.22M |
| 3 |
Renaissance Technologies
New York
|
+$830K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$688K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$516K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.82M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.49M |
| 3 |
IVAV
Index Venture Associates V
St. Helier, Channel Islands,
Jersey
|
-$863K |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$863K |
| 5 |
Millennium Management
New York
|
-$836K |
NERV Hedge Fund Activity: Q2 2019 in Review
85 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2019, worth a combined $163M — down 31% from $236M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NERV positions and 8 closed out — a net gain of 8 holders — while 24 added to existing stakes and 26 trimmed.
The largest buyer was Nuveen, opening a new position worth an estimated $1.25M. The largest seller was Wellington Management Group, exiting entirely with an estimated $4.82M sold.
- 85 institutional investors held Minerva Neurosciences (NERV) as of Q2 2019, up from 79 in Q1 2019.
- Funds reported $163M of Minerva Neurosciences stock for Q2 2019, down 31% quarter-over-quarter.
- 16 funds opened new Minerva Neurosciences positions in Q2 2019 and 8 closed out, a net change of +8 holders.
- The largest Minerva Neurosciences buyer in Q2 2019 was Nuveen, an estimated $1.25M added.
- The largest Minerva Neurosciences seller in Q2 2019 was Wellington Management Group, an estimated $4.82M sold.
Based on aggregated 13F filings for Q2 2019.